The dual-receptor mechanism produces maximum fat reduction over 6-12 months of treatment
The BPC-157 sequence is a partial fragment of a larger gastric protein, Body Protection Compound, first characterised in published research in the 1990s
Dizziness rates are similar between compounded injection and oral forms (both 5-8% in clinical use), though some patients report oral formulations cause less nausea, which can indirectly reduce vertigo symptoms
Lactobacillus fermentum ME-3 (4 billion CFU equivalent) Lactobacillus brevis KP08 (1 billion CFU equivalent) L-Carnitine Tartrate Vitamin C (as Ascorbic Acid) Vitamin D3 (plant sourced) Thiamin (Vitamin B1), Riboflavin (Vitamin B2), Niacin (Vitamin B3), Vitamin B6 Other Ingredients: Acacia fiber (prebiotic), vegetarian capsule (hypromellose), non-GMO rice hull concentrate (natural flow agent) Free from: milk, egg, fish, shellfish, tree nuts, gluten, peanuts, and soybeans
Categories: GLP-1 Support GLP-1 medications like semaglutide and tirzepatide can help manage a variety of chronic health conditions and support weight loss by reducing appetite and slowing digestion